SANTA CRUZ, Calif. — SomaGenics, an RNA-focused biotechnology company, announced expansion of its intellectual property portfolio with issue of two new patents for its RNA analysis technologies (miR-ID® and RealSeq®) and European patent protection for its therapeutic short synthetic hairpin RNA (sshRNA) agents. MiR-ID®, SomaGenics’ core technology for quantitative real-time PCR, enables accurate analysis of […]
Dr. Peter Robinson Recognized for Contributions to Clinical Genomics and Computational Biology SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today announced that Peter Robinson, M.D., MSC, has received an Agilent Thought Leader Award in recognition of his contributions to clinical genomics and computational biology. The award includes funding that will enable Dr. Robinson to […]
Bioinformatics expansion strengthens QIAGEN’s Sample to Insight metagenomics solutions Hilden, Germany, and Aarhus, Denmark – QIAGEN and CosmosID, a leading genomic big data company, today announced the launch of a metagenomics analysis plugin for the QIAGEN Microbial Genomics Pro Suite and CLC Genomics Workbench. The launch of the CosmosID plugin expands QIAGEN’s industry leading platform for NGS bioinformatics […]
BLUEBEE ATTAINS THE INFORMATION GOVERNANCE STATEMENT OF COMPLIANCE WHICH INCLUDES COMPLIANCE WITH THE NHS INFORMATION GOVERNANCE TOOLKIT (IGT) BOSTON, MA, USA — Boston, MA & Rijswijk, The Netherlands – Bluebee, a leading provider of high performance genomics solutions, today announced Bluebee Genomics Platform and its associated processes for development and operations have successfully obtained the Information […]
Horizon Discovery Partners with Sophia Genetics on NGS Reference Standards for Oncology Applications
Partnership combines Horizon’s HDx™ Reference Standards with Sophia Genetics’ artificial intelligence The use of Horizon’s Reference Standards will improve the quality of molecular profiling by SOPHiA™ artificial intelligence in oncology patient samples Users of the Sophia DDM® analytical platform will immediately benefit from the partnership to closely monitor the performance of their genomic tests LAUSANNE, […]
Reston, Va. — Parabon® NanoLabs (Parabon) announced today the award of a two-year Department of Defense (DoD) contract to develop a novel software platform for forensic analysis of DNA evidence. Many analysis products support traditional DNA typing, however, emerging methods, such as high-throughput DNA sequencing (HTS) and single nucleotide polymorphism (SNP) genotyping, require a collection […]
TUCSON, Ariz., and VENLO, the Netherlands —HTG Molecular Diagnostics, Inc. (HTGM) (“HTG”), a provider of instruments and reagents for molecular profiling applications and QIAGEN Manchester Limited, a wholly owned subsidiary of QIAGEN N.V. (QGEN) (Frankfurt Stock Exchange:QIA); “QIAGEN”), announced a Master Assay Development, Commercialization and Manufacturing Agreement (“Agreement”). This Agreement creates a framework for both […]
FREMONT, Calif. — WaferGen Bio-systems, Inc. (NASDAQ: WGBS), a publicly held genomics technology company (“WaferGen”), today announced that its stockholders have approved the adoption of the previously announced merger agreement by and among WaferGen, Takara Bio USA Holdings, Inc. (“Takara Bio”) and certain other parties thereto. “We are very pleased with the outcome of today’s […]
Enables Researchers to Seamlessly Transition from Cloud-based Genomic Data Analysis to Clinical Interpretation of Results CAMBRIDGE, Mass. – Seven Bridges, the biomedical data analysis company, and SolveBio today announced the integration of their complementary platforms for genomic data analysis. The integration of Seven Bridges’ platform for cloud-based biomedical data analysis with SolveBio enables biotech and pharmaceutical researchers […]
Multi-gene companion diagnostic designed to support patient selection for specific therapies in non-small cell lung cancer and multiple drug development programs CARLSBAD, Calif.–In its ongoing effort to help enable the era of precision therapies in oncology, Thermo Fisher Scientific today announced it has filed the final module of a premarket approval (PMA) application with the […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
